Agios Pharmaceuticals Inc. buy Citigroup Inc.
Start price
29.11.25
/
50%
€25.20
Target price
29.11.26
-
Performance (%)
16.67%
Price
31.03.26
€29.40
Summary
This prediction is currently active. The prediction currently has a performance of 16.67%. This prediction currently runs until 29.11.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | 19.512% | 19.512% |
| iShares Core DAX® | 0,75 % | -8,50 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % |
| iShares S&P 500 | -0,59 % | -2,87 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.00
05.03.26
05.03.26
€39.57
05.03.27
05.03.27
22.50%
31.03.26
31.03.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.80
26.12.25
26.12.25
-
26.12.26
26.12.26
23.53%
31.03.26
31.03.26